Contact 112-3201 Wilson St. Penticton, BC Canada V2A 8J3 cap@pompecanada.com Name Email Address Message 7 + 4 = Submit Recent Posts Audentes Therapeutics program update for Pompe disease Sarepta Therapeutics signs agreement with Lacerta Therapeutics, gaining rights to CNS-targeted Gene Therapy programs 2018 International Pompe Day #DYK Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at World Muscle Society AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease Share this:FacebookTwitterGoogleLinkedIn
